Veterinary Radiation Oncology of the Chesapeake, LLC

Businessfiled

Veterinary Radiation Oncology of the Chesapeake, LLC operates in Pharma, based in Annapolis.

Sub-sector tags: pharma.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Veterinary Radiation Oncology of the Chesapeake, LLC has raised $925K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $625K on 2019-01-02.

Most recent recorded round closed around 2019-01-02.

Valuation (modeled)modeled

Provath models Veterinary Radiation Oncology of the Chesapeake, LLC at approximately $30M (range $350K–$335M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.20× the median modeled value of Pre-Seed Pharma companies in 2019–2021 (20 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 1 months.

Last raise 7.5 yr ago; this sector typically re-raises about every 16 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 2.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 34% of Pharma peers (310 compared).

Modeled value ranks above 49% of those peers.

Closest niche peers: Jupiter Therapeutics, Inc., Tavros Therapeutics, Inc., Kalytera Therapeutics, Inc., Chamishi Therapeutics, Inc., Ikaika Therapeutics, Inc..

Peoplefiled

3 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.